These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4107009)

  • 1. [Preventive effect of menaquinone-4 (K2) on hypoprothrombinemia caused by dicumarol].
    Tajima T; Kawashima H; Kato Y; Ogo T; Miyao K
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):419-30. PubMed ID: 4107009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of menaquinone-4 (K2) on hypoprothrombinemia caused by warfarin].
    Tajima T; Kawashima H; Kato Y; Ogo T; Miyao K
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):412-8. PubMed ID: 5165263
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
    SOULIER JP; SOULLARD J
    Sang; 1952; 23(8):709-14. PubMed ID: 13004931
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin K treatment of sweet clover poisoning in calves.
    Alstad AD; Casper HH; Johnson LJ
    J Am Vet Med Assoc; 1985 Oct; 187(7):729-31. PubMed ID: 2414258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.
    SHOSHKES M; PERELMAN AJ
    J Am Med Assoc; 1956 Jul; 161(12):1145-7. PubMed ID: 13331775
    [No Abstract]   [Full Text] [Related]  

  • 6. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
    REHBEIN A; JARETZKI A; HABIF DV
    Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
    [No Abstract]   [Full Text] [Related]  

  • 7. Orally administered phytonadione in bishydroxycoumarin-induced hypoprothrombinemia.
    SHOSHKES M; ROBINS B; YELIN G
    J Am Med Assoc; 1957 Sep; 165(4):330-3. PubMed ID: 13462790
    [No Abstract]   [Full Text] [Related]  

  • 8. Don't use the wrong vitamin K.
    Udall JA
    Calif Med; 1970 Apr; 112(4):65-7. PubMed ID: 4191061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on dicumarol hypoprothrombinemia and vitamin K preparations; superiority of vitamin K1 oxide over menadione sodium bisulfite U.S.P. and synkayvite in reversing dicumarol hypoprothrombinemia.
    JAMES DF; BENNETT IL
    Arch Intern Med (Chic); 1949 Jun; 83(6):632-52. PubMed ID: 18152228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of vitamine K 1 on hypoprothrombinemia caused by dicumarol and on the acceleration factors in the rabbit with liver damage and the hepatectomized cat].
    JURGENS R
    Acta Haematol; 1952 Mar; 7(3):143-56. PubMed ID: 14952231
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of vitamin K on dicumarol-induced hypoprothrombinemia in rats.
    BOYD EJ; WARNER ED
    J Lab Clin Med; 1948 Nov; 33(11):1431-7. PubMed ID: 18890033
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.
    SHAPIRO S; WEINER M; SIMSON G
    N Engl J Med; 1950 Nov; 243(20):775-9. PubMed ID: 14780370
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.
    SHOSHKES M; GEYER RP; YEE GS; STARE FJ
    J Lab Clin Med; 1950 Oct; 36(4):531-6. PubMed ID: 14779068
    [No Abstract]   [Full Text] [Related]  

  • 14. The comparative effects of menadione sodium bisulfite and vitamin K1 on the hypoprothrombinemia induced by dicumarol.
    BANNON WG; OWEN CA; BARKER NW
    J Lab Clin Med; 1953 Mar; 41(3):393-404. PubMed ID: 13035275
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
    WATKIN DM; VAN ITALLIE TB; LOGAN WB; GEYER RP; DAVIDSON CS; STARE FJ
    J Lab Clin Med; 1951 Feb; 37(2):269-71. PubMed ID: 14814353
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemostatic effects of menaquinone-4 (K2) on various types of hemorrhagic diathesis in rats and comparison with other hemostatic agents].
    Tajima TO; Ogo T; Miyao K
    Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):478-85. PubMed ID: 4110973
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.
    OVERMAN RS; SORENSON CW; WRIGHT IS
    J Am Med Assoc; 1951 Feb; 145(6):393-9. PubMed ID: 14794454
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
    DOUGLAS AS; BROWN A
    Br Med J; 1952 Feb; 1(4755):412-5. PubMed ID: 14896166
    [No Abstract]   [Full Text] [Related]  

  • 19. Is hypoprothrombinemia caused by deficiency of vitamin K different from that of dicumarol?
    QUICK AJ; HUSSEY CV; COLLENTINE GE
    Proc Soc Exp Biol Med; 1952 Jan; 79(1):131-3. PubMed ID: 14892062
    [No Abstract]   [Full Text] [Related]  

  • 20. Mephyton (emulsified vitamin K1) in the treatment of excessive therapeutic hypoprothrombinemia.
    STRAGNELL R; WARE AG
    Med Clin North Am; 1954 Mar; 11():413-7. PubMed ID: 13153516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.